CHU de Bordeaux
Bordeaux, 33 076, France
NCT Number: NCT03604510
Tourette's syndrome (TS) is a debilitating and severe syndrome whose pathophysiology remains unclear.
In order to precise the cortical regions involved in the generation of tics, investigators will realize an electroencephalogram (EEG) recording in the frontal cortex of TS patients in ecological conditions (EEG-holter). Activity changes will be correlated with event markers of tics and neurovegetative parameters. Statistical analyses will be compared between epochs of EEG recording with tics and without tics. The aim is to define the cortical regions involved in the genesis of tics in order to consider new targets for cortical stimulation.
Looking for future studies?
Notify Me12 year–60 year
All sexes
Interventional
Not applicable
Bordeaux, 33 076, France
Gilles de la Tourette syndrome (GTS) is a childhood-onset disorder characterized by the presence of multiple motor tics and at least one vocal tic often associated with psychiatric co-morbidity. The expression of tics range from brief, recurrent and non-rhythmic motor or vocal actions (simple tics) to complex motor or vocal sequences (complex tics). The pathophysiology of tics is not yet fully understood. Recent imaging data suggest that the pattern of functional connectivity in cortico-basal ganglia networks is disrupted in GTS patients and could reflect a defect in brain maturation. However, regions involved in the immediate genesis of tics remains unknown since it is difficult to capture on line the cortical changes associated with tic generation using imaging techniques due to moving artefacts. Moreover, tics are much more frequent in everyday life conditions than in the artificial conditions of a laboratory. The aim is to study cortical activity changes occurring before tic occurrence by using long duration recording of encephalographic activity (EEG) in ecological conditions through Holter EEG techniques (24h recordings). Recordings will be performed in 15 patients with a severe form of Tourette's syndromes. EEG changes will be correlated to event markers, voluntary monitored by patients or automatically recorded (accelerometers for motor tics). EEG epoch centered on tics will be compared to similar epochs without tics. The occurrence of tics will also be correlated with neurovegetative markers of emotions such as RR interval ECG variability and skin resistivity changes. The ultimate goal of this project is to define a potential therapeutic target of tics for chronic cortical stimulation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no social insurance
24 hours of electroencephalographic recordings (EEG-Holter) of prefrontal activity of Tourette's syndrome (TS) patients in ecological conditions.
Time frame: During 24 hours
24 hours recording of encephalographic activity (EEG) in ecological conditions through Holter EEG.
Time frame: During 24 hours
Occurence of tic recorded by the patient with a button press connected with a case and automatically recorded with an accelerometers for motor tics.
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: During 24 hours
Intervals between R waves (RR interval) from the electrocardiogram
Time frame: During 24 hours
Skin conductance registered with a Bracelet sensor
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
University Hospital, Bordeaux
Other
Acronym: TIC-EEG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269953
Basal Ganglia Diseases, Brain Diseases
Nottingham, Nottinghamshire, United Kingdom
View Trial DetailsNCT05628805
Basal Ganglia Diseases, Brain Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT04978428
Anxiety Disorders, Basal Ganglia Diseases
Chicago, Illinois, United States
View Trial DetailsNCT05696769
Basal Ganglia Diseases, Behavior
Winston-Salem, North Carolina, United States
View Trial Details